References
- Munshi N MM, van de Velde H, Desai A, Potluri R, Vermeulen J. Use of a
Claims Database to Characterize and Estimate the Incidence Rate for
Castleman Disease. Leuk Lymphoma 2015;56(5):1252-1260.
- Casper C. The Aetiology and Management of Castleman Disease at 50
Years: Translating Pathophysiology to Patient Care Br J Haematol
2005;129: 3 – 17
- Carbone A, Borok M, Damania B, et al. Castleman disease. Nat Rev Dis
Primers 2021;7:84.
- Sopfe J, Endres A, Campbell K, et al. Castleman disease in pediatrics:
Insights on presentation, treatment, and outcomes from a two-site
retrospective cohort study. Pediatr Blood Cancer 2019;66:e27613.
- Bjarnason I, Cotes PM, Knowles S, Reid C, Wilkins R, Peters TJ. Giant
lymph node hyperplasia (Castleman’s disease) of the mesentery.
Observations on the associated anemia. Gastroenterology
1984;87:216-23.
- Kalayoğlu Beşışık S, Yönal Hindilerden İ, Hindilerden F, Doğan İ,
Beşışık F. A Rare Cause of Unexplained Refractory Iron Deficiency
Anemia: Unicentric Plasma-Cell Type Castleman’s Disease. Turk J
Haematol 2016;33:257-8.
- Parez N, Bader-Meunier, B., Roy, C. et al. Paediatric Castleman
disease: report of seven cases and review of the literature. European
Journal of Pediatrics 1999;158, 631–637.